Sodium glucose co-transporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis in the emergency peri-operative period: a systematic review
Journal of Anesthesia · 2025-12 · 39 (6) · 976-988
DOI: 10.1007/s00540-025-03570-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Anesthesia, online erschienen am 31.08.2025. Verfasst von Dennis Perez Castillo und 5 weiteren Autor:innen. Beteiligte Einrichtung: James Cook University, Townsville, Australia. dennis.perezcastillo@my.jcu.edu.au. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Sodium-Glucose Transporter 2 Inhibitors, Perioperative Care, Postoperative Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: James Cook University.
Abstract (Originalsprache)
Perioperative euglycaemic diabetic ketoacidosis (EuDKA) is a rare but life-threatening complication associated with sodium-glucose co-transporter-2 inhibitors (SGLT2i). It is characterised by ketonaemia, acidosis, and normal serum glucose. Whilst guidelines advise withholding SGLT2i prior to elective surgery, limited guidance exists for emergency procedures. This systematic review aimed to describe EuDKA cases following emergency surgery, identify patient characteristics, and examine contributing risk factors. A search of electronic databases up to April 2024 identified 30 cases from 21 publications. In most cases, EuDKA onset occurred within three days postoperatively (range: intraoperative to 10 days). Reported risk factors included inadequate SGLT2i withholding time, poor glycaemic control, morbid obesity, major surgery, intercurrent illness, suboptimal intraoperative diabetes management, and delayed gastrointestinal absorption. Morbidity was significant: ten patients required intensive care, two required intubation and ventilation, two received dialysis, and one underwent exploratory laparotomy. No deaths were reported. Due to atypical biochemical findings and non-specific symptoms, EuDKA remains under-recognised. Clinicians are advised to maintain a high index of suspicion, ensure appropriate perioperative insulin management, conduct vigilant laboratory monitoring, and provide patient education to reduce the risk in emergency surgical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- James Cook University, Townsville, Australia. dennis.perezcastillo@my.jcu.edu.au.
- James Cook University, Mackay, Australia.
- Townsville University Hospital, Townsville, Australia.
- James Cook University, Townsville, Australia.
ORCID-Profile: Dennis Perez Castillo
Förderung
- James Cook University
Zitieren
APA
Perez Castillo, D., Hall, L., Senthuran, S., Fox, E., Dash, S., & Heal, C. (2025). Sodium glucose co-transporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis in the emergency peri-operative period: a systematic review. Journal of Anesthesia, 39(6), 976-988. https://doi.org/10.1007/s00540-025-03570-2
Vancouver
Perez Castillo D, Hall L, Senthuran S, Fox E, Dash S, Heal C. Sodium glucose co-transporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis in the emergency peri-operative period: a systematic review. Journal of Anesthesia. 2025;39(6):976-988. doi:10.1007/s00540-025-03570-2
BibTeX
@article{PerezCastillo2025,
author = {Perez Castillo, Dennis and Hall, Leanne and Senthuran, Siva and Fox, Elliot and Dash, Sananta and Heal, Clare},
title = {Sodium glucose co-transporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis in the emergency peri-operative period: a systematic review},
journal = {Journal of Anesthesia},
year = {2025},
volume = {39},
number = {6},
pages = {976--988},
doi = {10.1007/s00540-025-03570-2}
}
EUVIMED